⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17451338 | 0.88 | TSHR (0.33) | — | |
| SCHEMBL5606648 | 0.79 | L3MBTL1 (0.33) | — | |
| Maleic Acid SCHEMBL11514645 | 0.78 | TSHR (0.45) | — | |
| Fumaric Acid SCHEMBL27584003 | 0.78 | TSHR (0.45) | — | |
| Fumaric Acid SCHEMBL8731888 | 0.78 | TSHR (0.45) | — | |
| Maleic Acid SCHEMBL11409606 | 0.78 | TSHR (0.45) | — | |
| SCHEMBL17923254 | 0.77 | L3MBTL1 (0.33) | — | |
| Fumaric Acid SCHEMBL9626562 | 0.74 | LMNA (0.42) | — | |
| SCHEMBL487392 | 0.74 | — | — | |
| SCHEMBL154825 | 0.73 | TSHR (0.38) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3201261-B1 | METHOD FOR CURING CURABLE COMPOSITIONS | BASF SE (DE) | 2018-12-12 | — | — | EP | claimed |
| EP-3201261-A1 | METHOD FOR CURING CURABLE COMPOSITIONS | BASF SE (DE) | 2017-08-09 | — | — | EP | claimed |
| WO-2016050398-A1 | METHOD FOR CURING CURABLE COMPOSITIONS | BASF SE (DE) | 2016-04-07 | — | — | WO | claimed |
| EP-0294294-B1 | Amine derivatives of anthracycline antibiotics | CYTOGEN CORP (US) | 1995-05-17 | — | — | EP | disclosed |
| US-5399738-A | Silanes, process for their preparation and their application to prepare polymers and polycondensates | FRAUNHOFER-GESELLSCHAFT ZUR FORDERUNG DER ANGEWANDTEN FORSCHUNG E.V. (DE) | 1995-03-21 | — | — | US | disclosed |
| US-5162512-A | Treatment of cellular disorders | CYTOGEN CORPORATION (US) | 1992-11-10 | — | — | US | disclosed |
| US-4950738-A | ANTICARCINOGENS | CYTOGEN CORPORATION (US) | 1990-08-21 | — | — | US | disclosed |
| WO-1988009823-A1 | AMINE DERIVATIVES OF ANTHRACYCLINE ANTIBIOTICS AND ANTIBODY CONJUGATES THEREOF | CYTOGEN CORPORATION (US) | 1988-12-15 | — | — | WO | disclosed |
| EP-0294294-A2 | Amine derivatives of anthracycline antibiotics | CYTOGEN CORPORATION (US) | 1988-12-07 | — | — | EP | disclosed |